About Neuraxpharm
Neuraxpharm is a company based in Langenfeld (Germany) founded in 2009 was acquired by Permira in September 2020. Neuraxpharm has completed 5 acquisitions, including Brain Therapeutics, Easypharm and FARMAX. Neuraxpharm operates in a competitive market with competitors including Jazz Pharmaceuticals, Lundbeck, Kriya Therapeutics, Sana Biotechnology and PureTech Health, among others.
- Headquarter Langenfeld, Germany
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Neuraxpharm Bohemia S.R.O.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Permira
& 1 more
-
Employee Count
Not available
-
Investments & Acquisitions
Brain Therapeutics
& 4 more
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Neuraxpharm
Unlock access to complete
Funding Insights of Neuraxpharm
Detailed funding history for Neuraxpharm
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Neuraxpharm
Neuraxpharm has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Permira and Apax Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Equity investments are focused on tech, services, and consumer sectors.
|
Locked | Locked | Locked | |
|
Investments are made in technology, consumer, healthcare, and service sectors.
|
Locked | Locked | Locked |
Investor details for Neuraxpharm
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Neuraxpharm
Neuraxpharm has strategically engaged in corporate development activities, having acquired 5 companies. Notable acquisitions include Brain Therapeutics, Easypharm and FARMAX.
Investment portfolio details for Neuraxpharm
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Diversified pharmaceutical drugs are distributed across Brazil.
|
Locked | Locked | 2021 | Locked | |
|
Seed oil and organic seed cannabis services are provided.
|
Locked | Locked | 2017 | Locked | |
|
Neurological services are offered at a standalone clinic in Athens.
|
Locked | Locked | 2012 | Locked |
Complete acquisition details for Neuraxpharm
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Neuraxpharm
Detailed financials for Neuraxpharm
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Neuraxpharm Comparisons
Peer comparison for Neuraxpharm
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Neuraxpharm
Neuraxpharm operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, Lundbeck, Kriya Therapeutics, Sana Biotechnology and PureTech Health, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| Locked | Locked | Locked |
Drugs for CNS disorders are developed and advanced.
|
|
| Locked | Locked | Locked |
Developer of therapeutic solutions for the treatment of diabetes
|
|
| Locked | Locked | Locked |
Genetically engineered cell therapies are developed for multiple disorders.
|
|
| Locked | Locked | Locked |
Immunotherapeutics are developed for inflammation, fibrosis, and lung diseases.
|
|
| Locked | Locked | Locked |
Therapies for neurological and neuropsychiatric diseases are developed.
|
Detailed competitors of Neuraxpharm
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Neuraxpharm
Complete news archive for Neuraxpharm
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Neuraxpharm
Neuraxpharm was founded in 2009.
Neuraxpharm is headquartered in Langenfeld, Germany. It is registered at Langenfeld, North Rhine-westphalia, Germany.
Jorg Thomas Dierks is the current CEO of Neuraxpharm.
Neuraxpharm was founded in 2009 and is headquartered in Langenfeld, Germany. Operations focus on the central nervous system sector, where established brands, value-added medicines, generics, consumer healthcare products, medical cannabis, digital health tools, medical devices, and orphan drugs are developed and commercialized. A broad portfolio of CNS treatment options is maintained to address patient needs across various conditions.
Neuraxpharm's top competitors include Jazz Pharmaceuticals, PTC Therapeutics and Biohaven Pharmaceutical.
Neuraxpharm has made 5 acquisitions, including Brain Therapeutics, Easypharm, and FARMAX.
Neuraxpharm has 2 investors. Key investors include Permira, and Apax Partners.